NASDAQ$PETS
PetMed Express · Q4 2022 earnings
Q4 2022 earnings · · Investor relations
Briefing
Announced financial results for the quarter and fiscal year ended March 31, 2022.
PetMed Express reported a decrease in net sales and net income for the quarter ended March 31, 2022. Net sales decreased by 7.9% to $66.0 million, and net income declined by 11% to $6.1 million, or $0.30 diluted earnings per share.
- Net sales for the quarter ended March 31, 2022, were $66.0 million, a decrease of 7.9% compared to the prior year quarter.
- Net income for the quarter ended March 31, 2022, was $6.1 million, or $0.30 diluted earnings per share, an 11% decrease from the prior year quarter.
- Adjusted EBITDA for the quarter was $9.5 million, or $0.47 diluted per share, compared to $10.4 million, or $0.52 diluted per share, for the quarter ended March 31, 2021.
- AutoShip subscription service grew to 37% of total revenue for the month of March.
Headline financials
Revenue & EPS history
PetMed Express · Revenue · Quarterly
$66M
Forward guidance
The company expects demand to normalize in the flea and tick and heartworm categories once the colder weather subsides and intends to continue to pay regular quarterly dividends; however, the declaration and payment of future dividends is discretionary.
Tailwinds
- Expect demand to normalize in flea and tick and heartworm categories
- Acceleration of AutoShip subscription service which grew to 37% of our total revenue for the month of March.
- The Board of Directors declared a quarterly dividend of $0.30 per share on the Company’s common stock.
- The dividend will be payable on May 27, 2022, to shareholders of record at the close of business on May 20, 2022.
- Continue to pay regular quarterly dividends
Headwinds
- Remains disappointed with the continued decline in sales
- A cooler March in most of the country delayed the usual start of the flea-and-tick season
- March's sales negatively impacted, resulting in a larger sales decline for the quarter
- Declaration and payment of future dividends is discretionary
- Subject to a determination by the Board of Directors each quarter following its review of the Company’s financial performance.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q4 2022
-0.0%
Avg return
Earnings day
-1.6%
Avg return
5 days after
-0.4%
Avg return
30 days after
42%
27 / 65 earnings
Positive
+40.8%
Q2 2020
Best reaction
-26.4%
Q2 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2026 | -16.4% | -21.1% | — | |
| Q3 2026 | -3.6% | -8.7% | -15.5% | |
| Q4 2025 | +0.0% | -4.9% | -6.6% | |
| Q2 2026 | -1.4% | -2.7% | -8.2% | |
| Q1 2026 | -1.1% | -1.4% | -6.9% | |
| Q3 2025 | -14.8% | -20.1% | -22.7% | |
| Q2 2025 | +34.5% | +27.2% | +35.0% | |
| Q1 2025 | -11.0% | -13.0% | -4.5% | |
| Q4 2024 | -0.7% | -1.7% | -7.4% | |
| Q3 2024 | +0.2% | -1.2% | +8.9% | |
| Q2 2024 | -26.4% | -23.0% | -22.6% | |
| Q1 2024 | -2.8% | -6.4% | -20.0% | |
| Q4 2023 | +6.7% | +1.0% | -6.6% | |
| Q3 2023 | -11.1% | -13.3% | -19.6% | |
| Q2 2023 | -10.5% | -4.7% | -15.5% | |
| Q1 2023 | +4.3% | +4.2% | +0.9% | |
| Q4 2022 | +6.9% | +2.0% | +3.0% | |
| Q3 2022 | +7.2% | +7.7% | +3.4% | |
| Q2 2022 | +5.1% | +5.1% | +5.2% | |
| Q1 2022 | +7.1% | +13.0% | +3.2% | |
| Q4 2021 | +2.8% | +0.5% | +56.5% | |
| Q3 2021 | -14.3% | -11.1% | +3.2% | |
| Q2 2021 | -2.2% | -3.5% | -1.9% | |
| Q1 2021 | -16.0% | -23.8% | -17.4% | |
| Q4 2020 | +3.6% | -4.0% | -7.5% | |
| Q3 2020 | -11.0% | -11.2% | +4.0% | |
| Q2 2020 | +40.8% | +32.8% | +21.7% | |
| Q1 2020 | +2.5% | -1.5% | +5.1% | |
| Q4 2019 | -9.0% | -9.7% | -18.9% | |
| Q3 2019 | -6.2% | -3.4% | -3.1% | |
| Q2 2019 | +2.6% | +1.1% | -9.7% | |
| Q1 2019 | -13.0% | -11.8% | -6.4% | |
| Q4 2018 | -0.9% | +1.4% | +15.1% | |
| Q3 2018 | -4.8% | -10.2% | -12.0% | |
| Q2 2018 | +4.4% | -5.0% | +9.0% | |
| Q1 2018 | +18.6% | +19.3% | -10.7% | |
| Q4 2017 | +34.7% | +41.2% | +48.4% | |
| Q3 2017 | -5.1% | -5.4% | -3.6% | |
| Q2 2017 | -3.2% | -4.0% | +6.6% | |
| Q1 2017 | +6.0% | +5.8% | +3.3% | |
| Q4 2016 | +2.9% | — | — | |
| Q3 2016 | -4.8% | — | — | |
| Q2 2016 | +2.1% | — | — | |
| Q1 2016 | +0.5% | — | — | |
| Q4 2015 | +2.6% | — | — | |
| Q3 2015 | +14.3% | — | — | |
| Q2 2015 | -3.7% | — | — | |
| Q1 2015 | +5.0% | — | — | |
| Q4 2014 | +1.6% | — | — | |
| Q3 2014 | -12.0% | — | — | |
| Q2 2014 | -10.3% | — | — | |
| Q1 2014 | +12.7% | — | — | |
| Q4 2013 | -0.5% | — | — | |
| Q3 2013 | +7.0% | — | — | |
| Q2 2013 | +6.9% | — | — | |
| Q1 2013 | -16.3% | — | — | |
| Q4 2012 | -5.4% | — | — | |
| Q4 2010 | -5.4% | — | — | |
| Q3 2011 | -0.2% | — | — | |
| Q3 2012 | -0.2% | — | — | |
| Q2 2012 | -0.8% | — | — | |
| Q2 2011 | -0.8% | — | — | |
| Q1 2012 | -0.1% | — | — | |
| Q1 2011 | -0.1% | — | — | |
| Q4 2011 | -0.1% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro